Global Blood Therapeutics Inc.

NASDAQ:GBT  
26.12
+0.66 (+2.59%)
Earnings Announcements

Gbt Reports First Quarter 2022 Financial Results

Published: 05/04/2022 21:53 GMT
Global Blood Therapeutics Inc. (GBT) - Gbt Reports First Quarter 2022 Financial Results.
Basic and Diluted Net Loss per Share for Three Months Ended March 31, 2022, Was $1.26.
Q1 Earnings per Share View $-1.31 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $64.39 Million
Adjusted EPS is expected to be -$1.19

Next Quarter Revenue Guidance is expected to be $73.31 Million
Next Quarter EPS Guidance is expected to be -$1.11

More details on our Analysts Page.